訊映 News Releases

Xunying Announces Completion of Treasury Stock Repurchase

Xunying has completed its treasury stock buyback program, acquiring 5 million shares for NT$75.46 mi… · 2026-07-09

Xunying's Key Subsidiary PRODIGY DIABETES CARE, LLC. Announces Board Resolution for Cash Dividend

PRODIGY DIABETES CARE, LLC., a key subsidiary of Xunying, has resolved to distribute a cash dividend… · 2026-07-08

Xunying's Key Subsidiary PRODIGY DIABETES CARE, LLC Announces Cash Dividend Record Date

PRODIGY DIABETES CARE, LLC, a key subsidiary of Xunying, announces the record date for cash dividend… · 2026-07-08

【Synergetics】2026-02 Monthly Revenue NT$106 Million (YoY +10.8%)

Synergetics announced its February 2026 revenue figures. The biotech and medical company reported a … · 2026-02-01

【Sync-Tech】Completion of Capital Reduction via Cancellation of Restricted Employee Shares

Sync-Tech completed the registration of capital reduction on May 25, 115, following the cancellation… · 2026-05-27

Hsin-Yin Corp. March 2026 Revenue NT$146 million (YoY -10.4%)

Hsin-Yin's monthly revenue for March 2026 was NT$146 million, a decrease of 10.4% year-over-year. Th… · 2026-03-01

[Xunying] Board Resolution to Distribute Cash Dividends for Important Subsidiary PRODIGY DIABETES CARE, LLC.

The Board of Directors of PRODIGY DIABETES CARE, LLC. resolved on June 10, 2023, to distribute cash … · 2026-06-10

【Announcement】Cumulative Share Repurchase Reaches 2% of Issued Shares, Announced as Required.

A company has completed this round of share repurchases, reaching 2% of issued shares, and announced… · 2026-06-10

[Press Release] PRODIGY DIABETES CARE, LLC., a Subsidiary of Daichiyou, Announces Cash Dividend Distribution Criteria Date

PRODIGY DIABETES CARE, LLC., a subsidiary of Daichiyou, has decided to distribute a cash dividend. T… · 2026-06-10

XinYing announces cash capital reduction

Cash reduction NT$144.8M, canceling 14.48M shares (~10%); objections by July 2, 2026. · 2026-06-02

Shin Ying: Key Resolutions from 115th Shareholders Meeting

Shin Ying's 2026-06-02 meeting approved NT$0.3 dividend, reports, and a capital reduction. · 2026-06-02

[HMD BioMedical] May 2026 Revenue reaches NT$139 million (YoY -3.0%)

HMD BioMedical (4155) announced its consolidated revenue for May 2026 at NT$139.23 million, represen… · 2026-05-01

【Signeo】On Behalf of Important Subsidiary PRODIGY DIABETES CARE, LLC., Announcement of Board Resolution to Distribute Cash Dividends

Signeo announced that its important subsidiary, PRODIGY DIABETES CARE, LLC., has resolved to distrib… · 2026-05-13

[Sinphar] Announcement on behalf of important subsidiary PRODIGY DIABETES CARE, LLC. regarding cash dividend record date

PRODIGY DIABETES CARE, LLC., an important subsidiary of Sinphar, announced the cash dividend record … · 2026-05-13

Inform Optoelectronics Board Approves Share Buyback of 5 Million Common Shares at NT0.00 to NT9.70 per Share

Inform Optoelectronics Co., Ltd. announced that its board of directors resolved on May 12, 2026, to … · 2026-05-12

Synaptics Optoelectronics: Board Resolution to Buy Back Company Shares

Synaptics Optoelectronics' board of directors has resolved to buy back up to 5 million ordinary shar… · 2026-05-12

[Xun Ying] Company Board of Directors Approves Consolidated Financial Report for Q1 115

Xun Ying's Board of Directors approved the consolidated financial report for Q1 115 (ending March 31… · 2026-05-12

[Syn-True] April 2026 Revenue 127 Million NTD (Year-on-Year -9.4%)

Syn-True announced April 2026 revenue of 127.2 million NTD, a 9.4% decrease year-on-year. This perfo… · 2026-04-01

[Signal Image] Announcement of the Board Meeting Date for the Company's Q1 2026 Financial Report

Signal Image Enterprise announced the board meeting notice issued on May 4, 2026, and the upcoming b… · 2026-05-04